Form 4: Clover Health CEO Sells Shares for Tax Obligations
Insider Transaction Report
Clover Health CEO Andrew Toy disposed of 85,704 Class A Common Stock shares to cover tax obligations related to RSU vesting.
Summary
- Andrew Toy, CEO and Director of Clover Health Investments, Corp., reported a transaction involving Class A Common Stock.
- On February 8, 2026, 85,704 shares of Class A Common Stock were disposed of at a price of $2.13 per share.
- This disposition represents shares automatically withheld to cover tax obligations upon the vesting of 6.25% of time-based restricted stock units (RSUs).
- The original RSU grant to Mr. Toy occurred on August 8, 2022.
- Following this transaction, Andrew Toy beneficially owns 9,423,021 shares of Class A Common Stock directly.
- The remaining RSUs are scheduled to vest quarterly in equal installments of 6.25%, with a final vesting date on August 8, 2026, contingent on Mr. Toy's continued service.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, representing a standard, non-discretionary transaction related to executive compensation and tax obligations, rather than a reflection of management's sentiment towards the company's future.
Positives
- The vesting of restricted stock units (RSUs) indicates a component of executive compensation being realized, aligning management's interests with long-term company performance.
Negatives
- The disposition of shares, while for tax purposes, represents a minor reduction in the CEO's direct equity holding in the company.
Future Outlook
The remaining restricted stock units (RSUs) granted to Andrew Toy are scheduled to vest quarterly in equal installments of 6.25%, with the final vesting occurring on August 8, 2026, provided he continues his service to the company.
Industry Context
StockSavvy.ai notes that this Form 4 filing details a routine insider transaction common among executives whose compensation includes restricted stock units. The sale of shares to cover tax obligations upon vesting is a standard practice and does not typically reflect a discretionary decision by the insider regarding the company's future prospects.
Stakeholder Impact
- Shareholders: A minor, non-discretionary dilution event due to RSU vesting and subsequent tax-related share disposition. The CEO's overall beneficial ownership remains substantial.
- Employees: The vesting of RSUs is a standard component of executive compensation, which can be seen as a positive for employee retention and motivation at the executive level.
Next Steps
- Continued quarterly vesting of remaining restricted stock units (RSUs) for Andrew Toy until the final vesting date of August 8, 2026.
Key Dates
| Date | Description |
|---|---|
| 08/08/2022 | Original grant date of time-based restricted stock units (RSUs) to Andrew Toy. |
| 02/08/2026 | Transaction date for the disposition of shares to cover tax obligations upon RSU vesting. |
| 02/10/2026 | Date the Form 4 was signed and filed. |
| 08/08/2026 | Final vesting date for the remaining restricted stock units, subject to continued service. |
Keywords
Clover Health, CLOV, Andrew Toy, Insider Transaction, Form 4, Restricted Stock Units, RSU Vesting, Tax Withholding, CEO Stock Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.